A 2013 meta-analysis reported a significant dose–response association (RR = 1.31) between IL-6 levels and the risk of T2DM, and a significant correlation between elevated CRP levels and an increased risk of T2DM (RR = 1.26) [3]. This evidence concerns the gene CRP and type 2 diabetes mellitus.